1. Home
  2. OCC vs EQ Comparison

OCC vs EQ Comparison

Compare OCC & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optical Cable Corporation

OCC

Optical Cable Corporation

HOLD

Current Price

$16.92

Market Cap

130.0M

Sector

Industrials

ML Signal

HOLD

EQ

Equillium Inc.

HOLD

Current Price

$2.62

Market Cap

129.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCC
EQ
Founded
1983
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.0M
129.0M
IPO Year
2001
2018

Fundamental Metrics

Financial Performance
Metric
OCC
EQ
Price
$16.92
$2.62
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
380.2K
1.0M
Earning Date
06-04-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
290.91
N/A
EPS
N/A
N/A
Revenue
$87,828,590.00
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.03
N/A
52 Week Low
$4.02
$0.36
52 Week High
$27.98
$3.54

Technical Indicators

Market Signals
Indicator
OCC
EQ
Relative Strength Index (RSI) 51.54 45.38
Support Level $4.80 $1.68
Resistance Level $27.98 $3.50
Average True Range (ATR) 1.58 0.27
MACD -0.22 -0.06
Stochastic Oscillator 49.02 27.96

Price Performance

Historical Comparison
OCC
EQ

About OCC Optical Cable Corporation

Optical Cable Corp manufactures a broad range of fiber optic and copper data communication cabling and connectivity solutions for the enterprise, wireless carrier, and specialty markets. The Company offers high quality products that operate as a system solution or integrate with other components, including fiber, copper, hybrid cabling, cabinets, racks, enclosures, and deployable solutions for enterprise networks, data centers, residential, campus, Passive Optical LAN installations, and customized applications in military, industrial, mining, petrochemical, renewable energy, and broadcast industries. It operates a single reportable segment covering the design, development, manufacture, and marketing of its cabling and connectivity solutions.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: